HIV/AIDS Co-Infection Therapy
Findings in HIV/AIDS co-infection therapy reported from P. Saiag and co-researchers
Published in AIDS Weekly, October 12th, 2009
Researchers detail in 'Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study,' new data in HIV/AIDS co-infection. According to recent research published in the British Journal of Dermatology, "Human immunodeficiency virus (HIV)+ patients have an increased risk of anogenital warts. High-risk (HR) human papillomaviruses (HPVs), especially types 16 and 18, are major risk factors for precancerous and cancerous lesions of the anogenital tract, while low-risk (LR) HPVs are associated with benign lesions."
"Cure of genital warts...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-10-12)
More Articles from AIDS Weekly
- McGill University Health Centre
Study highlights HIV/AIDS challenge in American prison system - Antiretrovirals
New data from Stanford University illuminate research in antiretrovirals - Antiretrovirals
Research from B.H. Chi and co-researchers yields new findings on antiretrovirals - Hepatitis C Virus
InterMune Announces Initiation of Ritonavir-Boosted ITMN-191/RG7227 Study in HCV Patients - HIV/AIDS
New HIV/AIDS findings from University of Witwatersrand published - HIV/AIDS
New HIV/AIDS findings from Y.Q. Tu and co-authors described - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
